Exciva
Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease
€51MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease
Develops inhaled therapies for severe respiratory diseases